Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Copyright 2023 – Finance News Network
07 Jul 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's portfolio of therapies.
16 Apr 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook talks about the growing demand for digital payments and the opportunities this presents for the company.
14 Jun 2023 - Australia holds the world's third largest amount of vanadium, behind China and Russia, but does not supply this critical mineral into the global market. Project Director Peter Hedley from Richmond Vanadium Technology (ASX:RVT) discusses the company's progress and the vanadium industry.
01 Mar 2021 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig talks about the company's strong 1H21 results on the back of a rebound in activity as the adverse impact of COVID disruptions diminishes.
24 May 2021 - BluGlass Limited (ASX:BLG) Non-Executive Director Jean-Michel Pelaprat talks about joining BluGlass, his experience, and the future for BluGlass's gallium nitride technology.
25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Juan Pablo Vargas de la Vega, Managing Director of Galan Lithium (ASX:GLN).
25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
09 Feb 2023 - Sequoia Asset Management Investment Manager Winston Sammut discusses property investment strategy, the impacts of COVID and work from home, shopping malls, industrial property, and alternative property classes.
23 Sep 2020 - Clayton Utz Partner Brendan Bateman discusses climate change risks, the legal duties of directors and how to factor such risks into financial valuations.
